• Study of Anifrolumab for Adults with Moderate-to-Severe Systemic Lupus Erythematosus

    Not recruiting

    4 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Germany Hungary Poland Spain

  • Study on the Effectiveness and Safety of Perampanel for Children with Epilepsy

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Belgium France Germany Spain

  • Study to Determine the Best Dose of Vesleteplirsen for Patients with Duchenne Muscular Dystrophy Suitable for Exon 51-Skipping Treatment

    Not recruiting

    2 1 1
    Investigated Drugs:
    Belgium Germany Italy The Netherlands Spain

  • Study on Mavacamten for Adults with Non-obstructive Hypertrophic Cardiomyopathy

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Czechia Denmark France Germany +7

  • Study of Relatlimab and Nivolumab with Chemotherapy for Patients with Stage IV or Recurrent Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Belgium France Germany Ireland Italy The Netherlands +3

  • Study Comparing Ponatinib and Imatinib with Chemotherapy for Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Austria France Greece Italy Poland Spain

  • Study on the Safety and Effects of ATL001 and Nivolumab for Adults with Metastatic or Recurrent Melanoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Study on the Safety and Effects of PTC518 for Patients with Huntington’s Disease

    Not recruiting

    2 1
    Investigated Drugs:
    Austria France Germany Italy The Netherlands Spain

  • Study on Cannabidiol as Add-on Therapy for Seizures in Patients Aged 1-65 with Tuberous Sclerosis Complex

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland

  • Study on Ublituximab and Drug Combination for Patients with Myasthenia Gravis or Relapsing Multiple Sclerosis

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland

powered by